Curve Therapeutics raises £40.5 million to turbocharge discovery platform and advance breakthrough pipeline

Series A financing led by Pfizer Ventures with new investors Columbus Venture Partners and British Patient Capital which join founding investor Advent Life Sciences and seed investor Epidarex CapitalGoal to advance proprietary discovery platform and progress pipeline of assets addressing challenging cancer targets into the clinicView original content:https://www.prnewswire.co.uk/news-releases/curve-therapeutics-raises-40-5-million-to-turbocharge-discovery-platform-and-advance-breakthrough-pipeline-302071547.html

en | boerse | 67983673 |